Avanos Medical, Inc. (AVNS)
NYSE: AVNS · IEX Real-Time Price · USD
19.50
-0.22 (-1.12%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Avanos Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Avanos Medical.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Avanos Medical stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 3 | 3 | 2 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 7, 2024 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 25, 2023 |
| Stifel | Stifel | Hold Reiterates $25 | Hold | Reiterates | $25 | +28.21% | Jun 21, 2023 |
| CL King | CL King | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +58.97% | May 22, 2023 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $28 → $26 | Sell | Maintains | $28 → $26 | +33.33% | May 4, 2023 |
Financial Forecast
Revenue This Year
709.31M
from 673.30M
Increased by 5.35%
Revenue Next Year
744.26M
from 709.31M
Increased by 4.93%
EPS This Year
1.40
from -1.32
EPS Next Year
1.84
from 1.40
Increased by 31.39%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 731.3M | 766.5M | 807.4M |
| Avg | 709.3M | 744.3M | 784.3M |
| Low | 680.8M | 714.7M | 753.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 8.6% | 8.1% | 8.5% |
| Avg | 5.3% | 4.9% | 5.4% |
| Low | 1.1% | 0.8% | 1.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.45 | 1.90 | 2.13 | 2.35 |
| Avg | 1.40 | 1.84 | 2.07 | 2.28 |
| Low | 1.34 | 1.76 | 1.99 | 2.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 35.5% | 15.6% | 13.6% |
| Avg | - | 31.4% | 12.3% | 10.3% |
| Low | - | 25.8% | 7.9% | 6.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.